LXEO NASDAQ
Lexeo Therapeutics, Inc. Common Stock
1W: -4.9%
1M: -17.4%
3M: -16.9%
YTD: -45.6%
1Y: +48.2%
$5.11
-0.12 (-2.29%)
Weekly Expected Move ±8.7%
$4
$5
$5
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026166
Institutions Holding
+9 vs prior
114.0%
Ownership
-109.42%
21
New
52
Increased
75
Reduced
43
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 3,342 | $5.06 | $17K | Filing |
| 2026-05-18 | Otero Jose Manuel | officer: chief operating officer | S-Sale | 1,302 | $5.07 | $7K | Filing |
| 2026-04-06 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 55,000 | $5.69 | $313K | Filing |
| 2026-03-13 | Townsend Richard Nolan | officer: chief executive officer | A-Grant/Award | 2,623 | $2.64 | $7K | Filing |
| 2026-03-13 | Otero Jose Manuel | officer: chief operating officer | A-Grant/Award | 5,930 | $2.64 | $16K | Filing |
| 2026-02-18 | Otero Jose Manuel | officer: chief operating officer | S-Sale | 3,016 | $6.40 | $19K | Filing |
| 2026-02-18 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 10,173 | $6.38 | $65K | Filing |
| 2026-02-13 | Bhalla Narinder Pal | officer: chief medical officer | A-Grant/Award | 49,500 | $— | $0 | Filing |
| 2026-02-04 | Tamayo Louis Edward | officer: chief financial officer | A-Grant/Award | 44,665 | $— | $0 | Filing |
| 2026-02-04 | Otero Jose Manuel | officer: chief operating officer | A-Grant/Award | 65,000 | $— | $0 | Filing |
| 2026-02-04 | Townsend Richard Nolan | officer: chief executive officer | A-Grant/Award | 161,665 | $— | $0 | Filing |
| 2025-11-18 | See Tai Sandi | officer: chief development officer | S-Sale | 386 | $9.27 | $4K | Filing |
| 2025-11-18 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 1,127 | $9.27 | $10K | Filing |
| 2025-11-18 | Robertson Jenny | officer: chief legal officer | S-Sale | 549 | $9.27 | $5K | Filing |
| 2025-11-18 | Otero Jose Manuel | officer: chief operating officer | S-Sale | 721 | $9.27 | $7K | Filing |
| 2025-11-18 | Adler Eric | officer: chief medical officer | S-Sale | 615 | $9.27 | $6K | Filing |
| 2025-10-17 | Otero Jose Manuel | officer: chief technical officer | S-Sale | 24 | $9.56 | $229 | Filing |
| 2025-10-17 | Otero Jose Manuel | officer: chief technical officer | S-Sale | 2,091 | $8.94 | $19K | Filing |
| 2025-10-17 | See Tai Sandi | officer: chief development officer | S-Sale | 44 | $9.56 | $421 | Filing |
| 2025-10-17 | See Tai Sandi | officer: chief development officer | S-Sale | 3,844 | $8.94 | $34K | Filing |
| 2025-10-17 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 148 | $9.56 | $1K | Filing |
| 2025-10-17 | Robertson Jenny | officer: chief legal officer | S-Sale | 40 | $9.56 | $382 | Filing |
| 2025-10-17 | Robertson Jenny | officer: chief legal officer | S-Sale | 3,486 | $8.94 | $31K | Filing |
| 2025-10-17 | Adler Eric | officer: chief medical officer | S-Sale | 38 | $9.56 | $363 | Filing |
| 2025-10-17 | Adler Eric | officer: chief medical officer | S-Sale | 3,344 | $8.94 | $30K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| CAXTON CORP | 13,943 | $80M | — | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 6,184,134 | $35M | +1,420,936 | 2026-03-31 | Filing |
| BlackRock, Inc. | 5,110,871 | $29M | +203,308 | 2026-03-31 | Filing |
| Affinity Asset Advisors, LLC | 5,050,211 | $29M | +1,850,211 | 2026-03-31 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 5,000,000 | $29M | — | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 4,976,429 | $29M | -533,206 | 2026-03-31 | Filing |
| Frazier Life Sciences Management, L.P. | 4,424,725 | $25M | — | 2026-03-31 | Filing |
| ORBIMED ADVISORS LLC | 3,602,450 | $21M | +1,477,450 | 2026-03-31 | Filing |
| STATE STREET CORP | 3,568,242 | $20M | +380,520 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,007,093 | $17M | +3,007,093 | 2026-03-31 | Filing |
| Woodline Partners LP | 2,750,532 | $16M | -447,228 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 1,949,885 | $11M | +1,168,030 | 2026-03-31 | Filing |
| Avoro Capital Advisors LLC | 1,875,000 | $11M | -1,425,000 | 2026-03-31 | Filing |
| Point72 Asset Management, L.P. | 1,680,449 | $10M | -214,273 | 2026-03-31 | Filing |
| Balyasny Asset Management L.P. | 1,589,585 | $9M | -45,441 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,513,777 | $9M | +67,890 | 2026-03-31 | Filing |
| ADAR1 Capital Management, LLC | 1,467,350 | $8M | +74,189 | 2026-03-31 | Filing |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,250,000 | $7M | — | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,103,584 | $6M | +240,692 | 2026-03-31 | Filing |
| Octagon Capital Advisors LP | 1,100,000 | $6M | -625,000 | 2026-03-31 | Filing |